Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $320.0.

  • Cellebrite DI's Shares Outstanding (Weighted Average) fell 7629.63% to $320.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $320.0, marking a year-over-year decrease of 7629.63%. This contributed to the annual value of $320.0 for FY2025, which is 7629.63% down from last year.
  • As of Q4 2025, Cellebrite DI's Shares Outstanding (Weighted Average) stood at $320.0, which was down 7629.63% from $240.0 recorded in Q3 2025.
  • Cellebrite DI's 5-year Shares Outstanding (Weighted Average) high stood at $190.2 million for Q4 2023, and its period low was $30.0 during Q2 2021.
  • In the last 5 years, Cellebrite DI's Shares Outstanding (Weighted Average) had a median value of $365.0 in 2023 and averaged $23.3 million.
  • Over the last 5 years, Cellebrite DI's Shares Outstanding (Weighted Average) had its largest YoY gain of 490000.0% in 2024, and its largest YoY loss of 9999.93% in 2024.
  • Cellebrite DI's Shares Outstanding (Weighted Average) (Quarter) stood at $30.0 in 2021, then skyrocketed by 608977816.67% to $182.7 million in 2022, then increased by 4.08% to $190.2 million in 2023, then crashed by 100.0% to $1350.0 in 2024, then crashed by 76.3% to $320.0 in 2025.
  • Its Shares Outstanding (Weighted Average) was $320.0 in Q4 2025, compared to $240.0 in Q3 2025 and $150.0 in Q2 2025.